Community-acquired methicillin-resistant Staphylococcus aureus in Switzerland : first surveillance report

C Aramburu1,2, S Harbarth3, N Liassine4

  • 1European Programme for Intervention Epidemiology Training, Geneva, Switzerland.

Insights

Community-acquired Methicillin-resistant Staphylococcus Aureus (CA-MRSA) infections are increasing. These infections involve virulent strains producing Panton-Valentine leukocidin (PVL). A surveillance system was established in Geneva in 2002.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Methicillin-resistant Staphylococcus Aureus (MRSA) is an emerging pathogen in the community.
  • Community-acquired MRSA (CA-MRSA) strains are often associated with Panton-Valentine leukocidin (PVL) and other potent exotoxins, contributing to increased virulence.
  • The emergence of PVL-producing CA-MRSA poses a significant public health threat.

Purpose of the Study:

  • To describe the emergence and surveillance of PVL-producing CA-MRSA in Geneva.
  • To establish a system for monitoring CA-MRSA infections in the community.

Main Methods:

  • Surveillance system established in Geneva for voluntary reporting of CA-MRSA cases.
  • Monitoring of PVL-producing CA-MRSA strains.

Main Results:

  • PVL-producing CA-MRSA was first identified in Geneva in 2002.
  • A voluntary reporting system was implemented to track these infections.

Conclusions:

  • PVL-producing CA-MRSA emerged as a community pathogen in Geneva starting in 2002.
  • Ongoing surveillance is crucial for managing and controlling CA-MRSA outbreaks.